Dorvis plus 20 mg/ml + 5 mg/ml kapi za oko, otopina
| Name | Dorvis plus 20 mg/ml + 5 mg/ml kapi za oko, otopina |
|---|---|
| Marketing Authorisation Number | HR-H-091461330 |
| Active Substance | dorzolamidklorid timololmaleat |
| Composition | jedan ml otopine sadrži 20 mg dorzolamida (u obliku dorzolamidklorida) i 5 mg timolola (u obliku timololmaleata) |
| Pharmaceutical Form | kapi za oko, otopina |
| Manufacturer | Rafarm S.A., Neo Psihiko Attiki, Grčka |
| Marketing Authorisation Holder | Zentiva k.s., U Kabelovny 130, Dolni Mecholupy, Prag 10, Češka |
| Marketing Authorisation Date | 06.10.2021 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/20-02/150 |
| Registration Number | 381-12-01/154-21-43 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | S01ED51 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
